IN2015DN02877A - - Google Patents
Info
- Publication number
- IN2015DN02877A IN2015DN02877A IN2877DEN2015A IN2015DN02877A IN 2015DN02877 A IN2015DN02877 A IN 2015DN02877A IN 2877DEN2015 A IN2877DEN2015 A IN 2877DEN2015A IN 2015DN02877 A IN2015DN02877 A IN 2015DN02877A
- Authority
- IN
- India
- Prior art keywords
- formula
- compound
- xii
- xiv
- xiii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a process for preparing a compound of formula: (Formula XI and XII) (XI) (XII) wherein X , Y , Z, A , B and E are as defined herein, by reacting a compound of formula: (Formula XIII) (XIII) with a compound of formula: (Formula XIV and XV) (XIV) (XV) respectively , in the presence of a transition metal catalyst , a ligand suitable for use with 15 the catalyst and a reducing agent. The invention also provides novel intermediates.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261713761P | 2012-10-15 | 2012-10-15 | |
| PCT/IB2013/059202 WO2014060900A1 (en) | 2012-10-15 | 2013-10-08 | Process for the preparation of voriconazole and analogues thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN02877A true IN2015DN02877A (en) | 2015-09-11 |
Family
ID=49641810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2877DEN2015 IN2015DN02877A (en) | 2012-10-15 | 2013-10-08 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9388167B2 (en) |
| EP (1) | EP2906555B1 (en) |
| JP (1) | JP6180533B2 (en) |
| KR (1) | KR101706488B1 (en) |
| CN (1) | CN104884450B (en) |
| AU (1) | AU2013333534B2 (en) |
| BR (1) | BR112015007821B1 (en) |
| CA (1) | CA2888127A1 (en) |
| CY (1) | CY1118451T1 (en) |
| DK (1) | DK2906555T3 (en) |
| ES (1) | ES2615743T3 (en) |
| HK (1) | HK1213891A1 (en) |
| HU (1) | HUE031877T2 (en) |
| IL (1) | IL238209A (en) |
| IN (1) | IN2015DN02877A (en) |
| MX (1) | MX358245B (en) |
| NZ (1) | NZ706764A (en) |
| PL (1) | PL2906555T3 (en) |
| PT (1) | PT2906555T (en) |
| RU (1) | RU2619928C2 (en) |
| SG (1) | SG11201502237RA (en) |
| SI (1) | SI2906555T1 (en) |
| WO (1) | WO2014060900A1 (en) |
| ZA (1) | ZA201501904B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201502237RA (en) * | 2012-10-15 | 2015-05-28 | Pfizer Ireland Pharmaceuticals | Process for the preparation of voriconazole and analogues thereof |
| CN106432198B (en) * | 2016-09-08 | 2022-10-21 | 浙江华海药业股份有限公司 | Method for preparing voriconazole split intermediate |
| CN112898273B (en) * | 2021-03-30 | 2022-05-31 | 海南锦瑞制药有限公司 | Synthetic method and application of voriconazole |
| CN113185465B (en) * | 2021-05-26 | 2022-09-27 | 无锡捷化医药科技有限公司 | Preparation method of 4-ethyl-5-aminopyrimidine |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8819308D0 (en) | 1988-08-13 | 1988-09-14 | Pfizer Ltd | Triazole antifungal agents |
| GB9002375D0 (en) | 1990-02-02 | 1990-04-04 | Pfizer Ltd | Triazole antifungal agents |
| GB9516121D0 (en) * | 1995-08-05 | 1995-10-04 | Pfizer Ltd | Organometallic addition to ketones |
| US20080194820A1 (en) * | 2004-12-14 | 2008-08-14 | Venkataraman Sundaram | Process For Preparing Voriconazole |
| PT1838718E (en) * | 2005-01-10 | 2011-08-17 | Pfizer | Pyrrolopyrazoles, potent kinase inhibitors |
| KR100889937B1 (en) * | 2007-08-06 | 2009-03-20 | 한미약품 주식회사 | Process for preparing voriconazole |
| WO2011045807A2 (en) * | 2009-10-14 | 2011-04-21 | Neuland Laboratories Ltd. | A novel process to manufacture (2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol |
| CN102827073A (en) * | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | Therapeutically active compositions and application methods thereof |
| CN103814020B (en) * | 2011-06-17 | 2017-07-14 | 安吉奥斯医药品有限公司 | Therapeutic activity composition and their application method |
| US9586931B2 (en) * | 2012-09-28 | 2017-03-07 | Merck Sharp & Dohme Corp. | Triazolyl derivatives as Syk inhibitors |
| SG11201502237RA (en) * | 2012-10-15 | 2015-05-28 | Pfizer Ireland Pharmaceuticals | Process for the preparation of voriconazole and analogues thereof |
| JO3383B1 (en) * | 2013-03-14 | 2019-03-13 | Lilly Co Eli | CDC7 Inhibitors |
-
2013
- 2013-10-08 SG SG11201502237RA patent/SG11201502237RA/en unknown
- 2013-10-08 SI SI201330487T patent/SI2906555T1/en unknown
- 2013-10-08 MX MX2015004450A patent/MX358245B/en active IP Right Grant
- 2013-10-08 AU AU2013333534A patent/AU2013333534B2/en active Active
- 2013-10-08 PL PL13795583T patent/PL2906555T3/en unknown
- 2013-10-08 WO PCT/IB2013/059202 patent/WO2014060900A1/en active Application Filing
- 2013-10-08 IN IN2877DEN2015 patent/IN2015DN02877A/en unknown
- 2013-10-08 DK DK13795583.7T patent/DK2906555T3/en active
- 2013-10-08 EP EP13795583.7A patent/EP2906555B1/en active Active
- 2013-10-08 CA CA2888127A patent/CA2888127A1/en not_active Abandoned
- 2013-10-08 PT PT137955837T patent/PT2906555T/en unknown
- 2013-10-08 ES ES13795583.7T patent/ES2615743T3/en active Active
- 2013-10-08 HU HUE13795583A patent/HUE031877T2/en unknown
- 2013-10-08 NZ NZ706764A patent/NZ706764A/en unknown
- 2013-10-08 RU RU2015113741A patent/RU2619928C2/en active
- 2013-10-08 CN CN201380052966.3A patent/CN104884450B/en active Active
- 2013-10-08 KR KR1020157009365A patent/KR101706488B1/en active IP Right Grant
- 2013-10-08 JP JP2015536261A patent/JP6180533B2/en active Active
- 2013-10-08 BR BR112015007821-4A patent/BR112015007821B1/en active IP Right Grant
- 2013-10-08 US US14/431,319 patent/US9388167B2/en active Active
-
2015
- 2015-03-19 ZA ZA2015/01904A patent/ZA201501904B/en unknown
- 2015-04-12 IL IL238209A patent/IL238209A/en active IP Right Grant
-
2016
- 2016-02-19 HK HK16101881.2A patent/HK1213891A1/en not_active IP Right Cessation
- 2016-04-20 US US15/133,621 patent/US9499520B2/en active Active
-
2017
- 2017-01-18 CY CY20171100072T patent/CY1118451T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX350892B (en) | Synthesis of antiviral compound. | |
| IN2012DN02751A (en) | ||
| MX2015002616A (en) | Synthesis of bis(fluorosulfonyl)imide. | |
| MY163187A (en) | Novel imidazo-oxazine compound or salt thereof | |
| MX2015017870A (en) | Process for manufacturing 4-propargylated amino-benzoxazinones. | |
| IN2015DN01061A (en) | ||
| PH12015501960B1 (en) | Processes for the preparation of an apoptosis-inducing agent | |
| MX349214B (en) | Process for manufacturing benzoxazinones. | |
| MX360806B (en) | Carbamat-benzoxazinones. | |
| NZ702935A (en) | Process for making hydroxylated cyclopentylpyrimidine compounds | |
| PH12018501642A1 (en) | Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof | |
| IN2014DN00144A (en) | ||
| MX2017017022A (en) | Method for the synthesis of rapamycin derivatives. | |
| IN2014DN09053A (en) | ||
| IN2015DN02877A (en) | ||
| IN2015DN00665A (en) | ||
| NZ720106A (en) | A process for the preparation of regadenoson | |
| MX363730B (en) | Method for producing substituted anthranilic acid derivatives. | |
| MX350430B (en) | Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-m ethyl-pentanoic acid compounds. | |
| MY168411A (en) | Method for preparing compound by novel michael addition reaction using water or various acids as additive | |
| MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
| GB2497841A (en) | Subsea hydrocarbon production system | |
| MX2014007421A (en) | Process for manufacturing aryloxyacetamides. | |
| CL2013001882A1 (en) | Industrial synthesis process of the compound of formula (i) agomelatine, from allyl cyanide; intermediary compounds | |
| IN2014DN10440A (en) |